Sign in

CIK 0001638287

  • Non-accelerated filer
  • Smaller reporting company

MetaVia Inc.

Sign in to watch
Ticker
MTVA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472389984
Phone
+1 857-702-9600
Business address
545 CONCORD AVENUE, SUITE 210, CAMBRIDGE, MA, 02138
Former names
NeuroBo Pharmaceuticals, Inc., Gemphire Therapeutics Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 19 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-07-24 KOUSKY KENNETH W Director Grant or award +15,000 26,935
2019-07-24 Reno Seth Chief Commercial Officer Grant or award +100,000 118,286
2019-07-24 Bisgaier Charles PhD Chief Scientific Off. & Chair Grant or award +100,000 1,348,914
2019-07-24 Gullans Steven R. Ph.D. President & CEO Grant or award +300,000 300,000
2018-05-22 Gullans Steven R. Ph.D. President & CEO Grant or award · Employee Stock Option (right to buy) +50,000 50,000
2018-05-22 Gullans Steven R. Ph.D. President & CEO Grant or award · Employee Stock Option (right to buy) +50,000 50,000
2018-05-01 Gullans Steven R. Ph.D. President & CEO Grant or award · Employee Stock Option (right to buy) +150,000 150,000
2018-02-08 Reno Seth Chief Commercial Officer Purchase +14,286 $7.00 $100K 18,286
2018-02-08 Gullans Steven R. Ph.D. Interim President & CEO Purchase +71,429 $7.00 $500K 930,252
2018-01-29 SASSINE ANDY Director Grant or award · Stock Option (right to buy) +10,800 10,800
2018-01-29 LICHTINGER PEDRO Director Grant or award · Stock Option(right to buy) +10,800 10,800
2018-01-29 KOUSKY KENNETH W Director Grant or award · Stock Option (right to buy) +10,800 10,800
2018-01-29 Hawryluk P. Kent Director Grant or award · Stock Option (right to buy) +10,800 10,800
2018-01-29 Gullans Steven R. Ph.D. Interim President & CEO Grant or award · Employee Stock Option (right to buy) +60,000 60,000
2018-01-28 Bisgaier Charles PhD Chief Scien Officer & Chair Grant or award · Stock Option (right to buy) +48,000 48,000
2018-01-28 Golden Lee Scott Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +148,000 148,000
2018-01-28 MATHIESEN JEFFREY S Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +48,000 48,000
2018-01-28 Reno Seth Chief Commercial Officer Grant or award · Employee Stock Option (right to buy) +48,000 48,000
2017-08-14 MATHIESEN JEFFREY S Chief Financial Officer Option exercise +3,207 $3.59 $12K 14,134
2017-08-14 MATHIESEN JEFFREY S Chief Financial Officer Option exercise · Employee Stock Option (right to buy) −3,207 0

Page 5 of 7 · 135 trades